Patents by Inventor Shannon Servoss

Shannon Servoss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTOID-PEPTIDE HYBRID, NMEG-aCGRP, AND ITS USE IN CARDIOVASCULAR DISEASES
    Publication number: 20220257711
    Abstract: NMEG-?CGRP, a biologically active molecule, and systems and methods of use therefore, subcutaneous administration of NMEG-?CGRP, a non-toxic peptoid-peptide hybrid that possesses hypotensive action, employed as a therapeutic agent to treat and prevent various cardiovascular diseases, including, heart failure (pressure. as well as volume, overload), myocardial infarction, cardiomyopathy, and hypertension.
    Type: Application
    Filed: July 31, 2020
    Publication date: August 18, 2022
    Applicants: University of South Carolina, Board of Trustees of the University of Arkansas
    Inventors: Jay D. Potts, Ambrish Kumar, Donald Dipette, Shannon Servoss
  • Peptoids and methods for attenuating inflammatory response
    Patent number: 11197908
    Abstract: Disclosed herein are peptoids and methods for attenuating inflammatory responses, and more particularly RAGE-associated inflammatory responses.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: December 14, 2021
    Assignees: The Board of Trustees of the University of Arkansas, University of South Carolina
    Inventors: Shannon Servoss, Melissa Moss, Lauren Wolf
  • PEPTOIDS AND METHODS FOR ATTENUATING INFLAMMATORY RESPONSE
    Publication number: 20200023032
    Abstract: Disclosed herein are peptoids and methods for attenuating inflammatory responses, and more particularly RAGE-associated inflammatory responses.
    Type: Application
    Filed: July 17, 2019
    Publication date: January 23, 2020
    Applicants: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Shannon Servoss, Melissa Moss, Lauren Wolf
  • Peptoids and methods for treating Alzheimer's disease
    Patent number: 10167315
    Abstract: Provided herein are peptoids capable of inhibiting or reversing amyloid ? (A?) fibril or plaque production. The peptoids form a helical structure with three monomers per helical turn and have at least four monomers with a side-chain having an arylalkyl or aryl group. The peptoid may be achiral. Also provided are methods of using the peptoids to inhibit or reverse aggregation of A? and methods of treating subjects with Alzheimer's disease (AD) or slowing the progression of AD.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: January 1, 2019
    Assignees: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Shannon Servoss, Melissa Moss, James Phillip Turner, Jr.
  • PEPTOIDS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20160376311
    Abstract: Provided herein are peptoids capable of inhibiting or reversing amyloid ? (A?) fibril or plaque production. The peptoids form a helical structure with three monomers per helical turn and have at least four monomers with a side-chain having an arylalkyl or aryl group. The peptoid may be achiral. Also provided are methods of using the peptoids to inhibit or reverse aggregation of A? and methods of treating subjects with Alzheimer's disease (AD) or slowing the progression of AD.
    Type: Application
    Filed: June 24, 2016
    Publication date: December 29, 2016
    Applicants: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, UNIVERSITY OF SOUTH CAROLINA
    Inventors: Shannon Servoss, Melissa Moss, James Phillip Turner, JR.
  • Peptoids and methods for treating alzheimer's disease
    Patent number: 8809275
    Abstract: Provided herein are peptoids capable of inhibiting or reversing amyloid ? (A?) fibril or plaque production. The peptoids form a helical structure with three monomers per helical turn and have at least two monomers with a side-chain having an arylalkyl group having the same chirality positioned such that the side-chains are on the same side of the peptoid. Also provided are methods of using the peptoids to inhibit or reverse aggregation of A? and methods of treating subjects with Alzheimer's disease (AD) or slowing the progression of AD.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: August 19, 2014
    Assignees: The Board of Trustees of the University of Arkansas, University of South Carolina
    Inventors: Shannon Servoss, Melissa Moss